Abstract:Objective To determine staging accuracy of double contrast-enhanced ultrasonography (DCUS)after neoadjuvant chemotherapy,and to evaluate effect during neoadjuvant chemotherapy for advanced gastric carcinoma(AGC).Methods A total of 29 patients with AGC diagnosed by endoscopy were examined and staged using ultrasound after taking oral contrast agent and bolus injection of SonoVue (DCUS)pre-and post-neoadjuvant chemotherapy.T-stage accuracy of post-neoadjuvant chemotherapy and pathological T status of postoperative were compared.All of the subjects were divided into two groups according to RECIST(Response Evaluation Criteria in Solid Tumors):chemotherapy benefit group(22cases,including:complete response 0 cases.partial response 14 cases,stable disease 8 cases)and progressive group(7 cases).The findings of DCUS of AGC tissues were assessed by auto-tracking contrast quantification(ACQ)software.The baseline intensity(BI)and peak intensity(PI)of gastric carcinoma tissues were measured automatically,and the enhanced intensity(EI)of gastric carcinoma tissues was calculated manually(EI =PI-BI).The quantitative analysis findings of DCUS of each patient pre-and postneoadjuvant chemotherapy between two groups were compared adopting repeated measures method.Results The overall accuracy of T staging in AGC patients after neoadjuvant chemotherapy were 65.52％ by DCUS,and 0,42.86％and 92.86％respectively for T2 stage,T3 stage and T4 stage.The agreement of this method was weak between T-stage accuracy post-neoadjuvant chemotherapy and pathological T status of postoperative.The Kappa value was 0.33.The difference value of PI and EI between pre-and postneoadjuvant chemotherapy in AGC patients for benefit group was more than that in progressive group.The main effect of BI in AGC tissues between pre-and post-neoadjuvant chemotherapy was no significant difference between two groups(P＞0.05).Conclusions Restaging by DCUS after neoadjuvant chemotherapy in AGC patients was found to be inaccurate.However,the difference value of PI and EI between pre-and post-neoadjuvant chemotherapy in AGC tissues for benefit group was more than that in progressive group.Thus,the value of PI and EI by ICUS may be a useful clinical parameter with which to evaluate the effect during neoadjuvant chemotherapy and guide therapeutic regimen for AGC patients.

The Value of PRETEXT Staging System Combined with CT Manisfestations for Evaluation of the Treatment of Hepatoblastoma in Children

Application of PRETEXT staging system in evaluating treatment response of children with hepatoblastoma

Pediatric Hepatoblastoma After Neoadjuvant Chemotherapy: Diagnostic Performance of MR in Staging POSTTEXT and Vascular Involvement

Applying Of Pretreatment Extent Of Disease System In Patients With Hepatocellular Carcinoma After Curative Partial Hepatectomy

Evaluation of the T-restaging and Effect after Neoadjuvant Chemotherapy in Advanced Gastric Carcinoma Using Double Contrast-Enhanced Ultrasonography

[Retrospective Analysis of 47 Cases with Hilar Cholangiocarcinoma Using T-staging System].

The Chinese Classification System Compared with TNM Staging in Prognosis of Patients with Primary Hepatic Carcinoma after Resection.

A comparison of three different staging systems of hilar cholangiocarcinoma

Surgical Resection of Pediatric PRETEXT III and IV Hepatoblastoma: A Retrospective Study Investigating the Need for Preoperative Chemotherapy

Diagnosis and Treatment of Hepatoblastoma in Children

Prognostic Performance of the China Liver Cancer Staging System in Hepatocellular Carcinoma Following Transarterial Chemoembolization.

A Follow-Up Report of Childhood Hepatoblastoma from 74 Cases in a Single Center

Model of Multidisciplinary Team Treatment on Hepatoblastoma in Children

COMBINED TREATMENT OF HEPATOBLASTOMA WITH TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION AND SURGERY

Value of MR and CT in Preoperative Staging and Resectability Assessment of Pancreatic Carcinoma

Prognostic Value of Preoperative Computed Tomography in HBV-related Hepatocellular Carcinoma Patients after Curative Resection

Preoperative interventional therapy for children with unresectable hepatoblastoma

Retrospective Analysis of Childhood Hepatoblastoma in a Single Centre in China.

CT and MRI Manifestations of Hepatoblastoma

A New Staging System for Hepatocellular Carcinoma Associated with Portal Vein Tumor Thrombus

Comparison of four current staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection: Okuda, CLIP, TNM and CUPI